Timing Pharmaceutical Co

Timing Pharmaceutical Co Gross Margin

The Gross Margin of Timing Pharmaceutical Co (6659.TWO) as of Oct 31, 2026 is 32.76 %. In the previous year, Gross Margin was 31.31 % — a change of 4.65% (higher).

Gross Margin

32.76 %

YoY

4.65%

Last updated:

Gross Margin of Timing Pharmaceutical Co is 2024 32.76 % . Gross Margin of Timing Pharmaceutical Co was 2023 31.31 % . It decreases by 4.65% higher compared to the previous year.

For Timing Pharmaceutical Co, the gross margin of 32.8% is broadly stable versus 33.5% a few years ago.

The Timing Pharmaceutical Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2022
33.45 TWD
Jan 1, 2023
31.31 TWD
Jan 1, 2024
32.76 TWD
The Timing Pharmaceutical Co Gross Margin history
YEARGross MarginYoY
32.76 %+4.65%
31.31 %-6.41%
33.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co Ltd generates revenue through manufacturing concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations for domestic and overseas markets. The company accepts applications for licenses and permits related to Chinese medicine, food, and pharmaceutical products, and offers contract manufacturing services. Its comprehensive sales network covers Chinese medicine hospitals and major pharmacies across Taiwan, supported by a professional supply chain and service network. The firm also provides testing services and CDMO services for new pilot projects in research and development. The primary buyers of Timing Pharmaceutical's products include Chinese medicine hospitals, major pharmacies, and overseas markets. Domestic sales are facilitated through a full-fledged professional supply chain and service network, while overseas markets are served through direct exports and partnerships. The company's focus on traditional Chinese medicine and pharmaceuticals drives demand from healthcare institutions and consumers seeking natural health solutions. Timing Pharmaceutical Co Ltd invests annually in research and development for new pilot projects, which are supported by its contract research and development and manufacturing organization (CDMO) services. These services are contracted by clients seeking to develop and manufacture pharmaceutical products, including traditional Chinese medicine formulations. The company's portfolio includes concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations, all of which are distributed through its established network. Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Timing Pharmaceutical Co stock

Gross Margin of Timing Pharmaceutical Co is 32.76 % in 2024.

Gross Margin of Timing Pharmaceutical Co changed from 31.31 % to 32.76 %, representing a 4.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Timing Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Timing Pharmaceutical Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Timing Pharmaceutical Co